Boudreau Helen M 4

What Happened

• Helen M. Boudreau, a director of Shattuck Labs, was granted a derivative award on 2026-05-29 giving her the right to purchase 81,000 shares of the company’s common stock. The reported acquisition price is $0.00 (the filing lists this as an award/derivative grant), and no shares were exercised or sold in this transaction.

Key Details

• Transaction date: 2026-05-29; filing date (Form 4): 2026-06-02 (timely filed within SEC rules).
• Reported acquisition: 81,000-share option/award; reported price: $0.00; reported value: $0.
• Shares owned after transaction: not specified in the provided filing data.
• Footnote: The award vests in full on the earlier of the one-year anniversary of the grant date or immediately prior to the issuer’s next annual meeting of stockholders, subject to continued service by the reporting person.
• No indication of a 10b5-1 plan, tax-withholding sale, or immediate cashless exercise in this filing.

Context

• This was a grant of an equity-based award (a right to purchase shares) typically used for director compensation. It is not an exercise or sale, and does not by itself indicate buying/selling sentiment—vesting and future exercise would determine any eventual ownership change or sales.